Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

NCT02260687 · clinicaltrials.gov ↗

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Choroidal Neovascularization

Interventions

DRUG: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Sponsor

Bayer

Collaborators

[object Object]